M3, Inc., a Japanese healthcare investment firm, is acquiring Messly, a London-based company which aims to combat NHS staffing shortages.
Christopher Kurwie and Abrar Gundroo, founders of Messly, have sold their businesses to M3 for an undisclosed price. The pair had jointly control just under 50% of the share capital of Messly, which they founded in 2017.
Messly is a recruiting marketplace platform for U.K. doctors, for surgeries and hospitals to hire locums, or temporary doctors, at short notice. According to the press release, around 70% of trainee doctors in the United Kingdom have registered with Messly.
M3, Inc. is. The company was founded in 2000 and is headquartered in Tokyo. M3, which is listed on the Tokyo Stock Exchange, already owns a number of U.K. businesses focused on NHS staffing, including Remedium, an international physician recruiting company, and Rotamaster, a rostering and workforce management software for medical institutions.
According to data captured from the LevinPro HC database, this acquisition represents the 20th healthcare staffing transaction of 2023. This is slightly slower than last year, when there were 22 healthcare staffing deals reported between January 1, 2022, and August 21, 2022.
